• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

柬埔寨艾滋病毒感染者中丙型肝炎的横断面研究:患病率、危险因素及针对性筛查的可能性

A cross-sectional study of hepatitis C among people living with HIV in Cambodia: Prevalence, risk factors, and potential for targeted screening.

作者信息

De Weggheleire Anja, An Sokkab, De Baetselier Irith, Soeung Pisith, Keath Huy, So Veasna, Ros Sreyphors, Teav Syna, Smekens Bart, Buyze Jozefien, Florence Eric, van Griensven Johan, Thai Sopheak, Francque Sven, Lynen Lutgarde

机构信息

Department of Clinical Sciences, Institute of Tropical Medicine Antwerp, Antwerp, Belgium.

Infectious Diseases, Sihanouk Hospital Center of Hope, Phnom Penh, Cambodia.

出版信息

PLoS One. 2017 Aug 23;12(8):e0183530. doi: 10.1371/journal.pone.0183530. eCollection 2017.

DOI:10.1371/journal.pone.0183530
PMID:28832660
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5568279/
Abstract

The epidemiology of hepatitis C in Cambodia is not well-known. We evaluated the prevalence of hepatitis C virus (HCV) and risk factors in the HIV cohort of Sihanouk Hospital Center of Hope in Phnom Penh to strengthen the evidence for suitable HCV testing strategies among people living with HIV (PLWH) in Cambodia. All consenting adult PLWH without a history of HCV treatment were tested for HCV between November 2014 and May 2016 according to the CDC algorithm (HCV antibody II electro-chemiluminescence immunoassay, followed by COBAS® AmpliPrep/COBAS® TaqMan® HCV PCR and INNO-LIA® HCV Score immunoblot end-testing). Genotyping was performed using the line probe assay Versant HCV genotype 2.0®. The study enrolled a total of 3045 patients (43% males, median age: 42.5 years, <1% high-risk). HCV antibodies were detected in 230 (7.6%; 95% confidence interval [CI] 6.6-8.5). Upon further testing, HCV antibodies were confirmed in 157 (5.2%; 95% CI 4.4-6.0) and active HCV in 106 (3.5%; 95% CI 2.8-4.2). Viremic prevalence peaked among men aged 50-55 years (7.3%) and women aged >55 years (11.2%). Genotype 1b (45%) and 6 (41%) were predominant. Coinfected patients had a higher aspartate-to-platelet ratio index, lower platelets, a lower HBsAg positivity rate and more frequent diabetes. Based on logistic regression, blood transfusion antecedents (adjusted odds ratio 2.9; 95% CI 1.7-4.9), unsafe medical injections (2.0; 1.3-3.2), and partner (3.4; 1.5-7.6) or household member (2.4; 1.3-3.2) with liver disease were independently associated with HCV in women. However, having a tattoo/scarification (1.9; 1.1-3.4) and household member (3.1; 1.3-7.3) with liver disease were associated with HCV in men. Thus, our study found intermediate endemicity of active hepatitis C in a large Cambodian HIV cohort and provides initial arguments for targeted HCV screening (>50 years, partner/household member with liver disease, diabetes, increased aspartate-to-platelet ratio index) as efficient way forward.

摘要

柬埔寨丙型肝炎的流行病学情况尚不为人所知。我们评估了金边市西哈努克希望医院中心艾滋病队列中丙型肝炎病毒(HCV)的流行情况及风险因素,以强化柬埔寨艾滋病感染者(PLWH)中合适的HCV检测策略的证据。2014年11月至2016年5月期间,所有同意参与研究且无HCV治疗史的成年PLWH,均按照美国疾病控制与预防中心(CDC)的算法接受HCV检测(HCV抗体II电化学发光免疫测定,随后进行COBAS® AmpliPrep/COBAS® TaqMan® HCV PCR检测以及INNO-LIA® HCV Score免疫印迹终末检测)。采用线性探针检测法Versant HCV genotype 2.0®进行基因分型。该研究共纳入3045例患者(43%为男性,中位年龄:42.5岁,高危人群占比<1%)。230例(7.6%;95%置信区间[CI] 6.6 - 8.5)检测出HCV抗体。进一步检测后,157例(5.2%;95% CI 4.4 - 6.0)确诊为HCV抗体阳性,106例(3.5%;95% CI 2.8 - 4.2)为活动性HCV感染。病毒血症患病率在50 - 55岁男性(7.3%)和>55岁女性(11.2%)中达到峰值。基因型1b(45%)和6型(41%)占主导地位。合并感染患者的天冬氨酸与血小板比值指数更高、血小板计数更低、乙肝表面抗原(HBsAg)阳性率更低且糖尿病更为常见。基于逻辑回归分析,输血史(调整比值比2.9;95% CI 1.

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/873b/5568279/b8e1c3f462de/pone.0183530.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/873b/5568279/a371e0663d16/pone.0183530.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/873b/5568279/35fa058f00d3/pone.0183530.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/873b/5568279/b8e1c3f462de/pone.0183530.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/873b/5568279/a371e0663d16/pone.0183530.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/873b/5568279/35fa058f00d3/pone.0183530.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/873b/5568279/b8e1c3f462de/pone.0183530.g003.jpg

相似文献

1
A cross-sectional study of hepatitis C among people living with HIV in Cambodia: Prevalence, risk factors, and potential for targeted screening.柬埔寨艾滋病毒感染者中丙型肝炎的横断面研究:患病率、危险因素及针对性筛查的可能性
PLoS One. 2017 Aug 23;12(8):e0183530. doi: 10.1371/journal.pone.0183530. eCollection 2017.
2
Hepatitis C seroprevalence among people living with HIV/AIDS and pregnant women in four provinces in Cambodia: an integrated bio-behavioral survey.柬埔寨四个省份的 HIV/AIDS 感染者和孕妇中的丙型肝炎血清流行率:一项综合生物行为调查。
BMC Infect Dis. 2022 Feb 22;22(1):177. doi: 10.1186/s12879-022-07163-2.
3
Comparison of predictive models for hepatitis C co-infection among HIV patients in Cambodia.柬埔寨 HIV 患者丙型肝炎合并感染预测模型的比较。
BMC Infect Dis. 2020 Mar 12;20(1):209. doi: 10.1186/s12879-020-4909-z.
4
Development of a risk score to guide targeted hepatitis C testing among human immunodeficiency virus patients in Cambodia.柬埔寨人类免疫缺陷病毒患者中用于指导针对性丙型肝炎检测的风险评分的制定。
World J Hepatol. 2021 Sep 27;13(9):1167-1180. doi: 10.4254/wjh.v13.i9.1167.
5
Human immunodeficiency virus type 1 and hepatitis C virus co-infection and viral subtypes at an HIV testing center in Brazil.巴西一家艾滋病检测中心的1型人类免疫缺陷病毒与丙型肝炎病毒合并感染及病毒亚型情况
J Med Virol. 2006 Jun;78(6):719-23. doi: 10.1002/jmv.20613.
6
Prevalence of hepatitis C and coinfection with HIV among United States veterans in the New York City metropolitan area.纽约市大都市区美国退伍军人中丙型肝炎的患病率及与艾滋病毒的合并感染情况。
Am J Gastroenterol. 2002 Aug;97(8):2071-8. doi: 10.1111/j.1572-0241.2002.05924.x.
7
Prevalence of hepatitis C in an ethnically diverse HIV-1-infected cohort in south London.伦敦南部一个种族多样的HIV-1感染队列中丙型肝炎的患病率。
HIV Med. 2005 May;6(3):206-15. doi: 10.1111/j.1468-1293.2005.00291.x.
8
Major risk of blood transfusion in hemolytic anemia patients.溶血性贫血患者输血的主要风险。
Blood Coagul Fibrinolysis. 2011 Jun;22(4):280-4. doi: 10.1097/MBC.0b013e3283451255.
9
Risk factors for hepatitis C transmission in HIV patients, Hepacam study, ANRS 12267 Cambodia.柬埔寨 Hepacam 研究:HIV 患者丙型肝炎传播的风险因素,ANRS 12267。
AIDS Behav. 2014 Mar;18(3):495-504. doi: 10.1007/s10461-013-0486-0.
10
Hepatitis C prevalence among HIV-infected patients in Guinea-Bissau: a descriptive cross-sectional study.几内亚比绍艾滋病毒感染患者中的丙型肝炎患病率:一项描述性横断面研究。
Int J Infect Dis. 2014 Nov;28:35-40. doi: 10.1016/j.ijid.2014.06.007. Epub 2014 Sep 16.

引用本文的文献

1
Post-Diagnosis HCV RNA Testing Rates Prior to HCV Treatment Among People Living With HIV With HCV Antibody Positivity in the Asia-Pacific Region.亚太地区抗 HCV 抗体阳性的 HIV 感染者在 HCV 治疗前的诊断后 HCV RNA 检测率。
J Viral Hepat. 2024 Nov;31(11):686-699. doi: 10.1111/jvh.13993. Epub 2024 Aug 8.
2
Hepatitis B and C viral coinfection and associated factors among HIV-positive patients attending ART clinics of Afar regional state, northeast Ethiopia.埃塞俄比亚东北部阿法尔州接受抗逆转录病毒治疗诊所的 HIV 阳性患者中乙型和丙型肝炎病毒合并感染及相关因素。
PLoS One. 2024 May 16;19(5):e0302453. doi: 10.1371/journal.pone.0302453. eCollection 2024.
3

本文引用的文献

1
Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study.2015 年全球丙型肝炎病毒感染的流行率和基因型分布:一项建模研究。
Lancet Gastroenterol Hepatol. 2017 Mar;2(3):161-176. doi: 10.1016/S2468-1253(16)30181-9. Epub 2016 Dec 16.
2
Hepatitis C virus (HCV) RNA profiles among chronic HIV/HCV-coinfected individuals in ESPRIT; spontaneous HCV RNA clearance observed in nine individuals.在 ESPRIT 中慢性 HIV/HCV 合并感染个体中的丙型肝炎病毒 (HCV) RNA 谱;九名个体中观察到自发 HCV RNA 清除。
HIV Med. 2017 Jul;18(6):430-434. doi: 10.1111/hiv.12466. Epub 2016 Oct 26.
3
Trends in hepatitis C virus coinfection and its cascade of care among adults living with HIV in Asia between 2010 and 2020.
2010 年至 2020 年亚洲地区 HIV 感染者中丙型肝炎病毒合并感染及其治疗情况的变化趋势。
PLoS One. 2023 Jun 28;18(6):e0287909. doi: 10.1371/journal.pone.0287909. eCollection 2023.
4
Meta-analysis: risk of hepatitis C virus infection associated with hospital-based invasive procedures.Meta 分析:医院有创操作相关丙型肝炎病毒感染风险。
Aliment Pharmacol Ther. 2022 Aug;56(4):558-569. doi: 10.1111/apt.17106. Epub 2022 Jun 27.
5
Prevalence and genotype distribution of viral hepatitis B in Cambodia between 1990 and 2020: a systematic review and meta-analysis.1990年至2020年柬埔寨乙型病毒性肝炎的患病率和基因型分布:一项系统评价和荟萃分析
Arch Public Health. 2022 Apr 13;80(1):119. doi: 10.1186/s13690-022-00880-9.
6
Viral hepatitis and the cascade of care among people living with HIV in the Asia-Pacific.亚太地区艾滋病毒感染者中的病毒性肝炎和关怀链。
HIV Med. 2022 Oct;23(9):959-968. doi: 10.1111/hiv.13280. Epub 2022 Feb 25.
7
Hepatitis C seroprevalence among people living with HIV/AIDS and pregnant women in four provinces in Cambodia: an integrated bio-behavioral survey.柬埔寨四个省份的 HIV/AIDS 感染者和孕妇中的丙型肝炎血清流行率:一项综合生物行为调查。
BMC Infect Dis. 2022 Feb 22;22(1):177. doi: 10.1186/s12879-022-07163-2.
8
Costing analysis of field implementation of hepatitis C case detection in rural Maung Russey operational district, Cambodia.柬埔寨蒙乐瑞西农村操作区丙型肝炎病例检出的现场实施成本分析。
Western Pac Surveill Response J. 2021 Jul 12;12(3):17-24. doi: 10.5365/wpsar.2020.11.3.006. eCollection 2021 Jul-Sep.
9
Development of a risk score to guide targeted hepatitis C testing among human immunodeficiency virus patients in Cambodia.柬埔寨人类免疫缺陷病毒患者中用于指导针对性丙型肝炎检测的风险评分的制定。
World J Hepatol. 2021 Sep 27;13(9):1167-1180. doi: 10.4254/wjh.v13.i9.1167.
10
Hepatitis B and C infections in HIV-1 patients on combination antiretroviral therapy (cART) in Ghana: implications for immunologic recovery, clinical response to treatment, and hepatotoxicity.加纳接受联合抗逆转录病毒疗法(cART)的HIV-1患者中的乙型和丙型肝炎感染:对免疫恢复、治疗临床反应及肝毒性的影响
Heliyon. 2021 May 28;7(6):e07172. doi: 10.1016/j.heliyon.2021.e07172. eCollection 2021 Jun.
Hepatitis C Is Poorly Associated With Drug Use in Cambodian Americans in Lowell, Massachusetts.
在马萨诸塞州洛厄尔的柬埔寨裔美国人中,丙型肝炎与药物使用之间的关联不大。
Open Forum Infect Dis. 2016 May 12;3(2):ofw099. doi: 10.1093/ofid/ofw099. eCollection 2016 Apr.
4
The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013.1990年至2013年病毒性肝炎的全球负担:全球疾病负担研究2013的结果。
Lancet. 2016 Sep 10;388(10049):1081-1088. doi: 10.1016/S0140-6736(16)30579-7. Epub 2016 Jul 7.
5
Prevalence and Disease Burden of HCV Coinfection in HIV Cohorts in the Asia Pacific Region: A Systematic Review and Meta-Analysis.亚太地区艾滋病毒队列中丙型肝炎病毒合并感染的患病率和疾病负担:一项系统评价和荟萃分析。
AIDS Rev. 2016 Apr-Jun;18(2):68-80.
6
Direct-acting antiviral treatment in adults infected with hepatitis C virus: Reactivation of hepatitis B virus coinfection as a further challenge.直接作用抗病毒治疗成人丙型肝炎病毒感染:乙型肝炎病毒合并感染的再激活是一个进一步的挑战。
J Clin Virol. 2016 May;78:27-30. doi: 10.1016/j.jcv.2016.02.026. Epub 2016 Mar 3.
7
Hepatitis B and C Co-Infection in HIV Patients from the TREAT Asia HIV Observational Database: Analysis of Risk Factors and Survival.来自亚太地区HIV观察数据库的HIV患者中乙型肝炎和丙型肝炎合并感染:危险因素与生存分析
PLoS One. 2016 Mar 2;11(3):e0150512. doi: 10.1371/journal.pone.0150512. eCollection 2016.
8
Prevalence and burden of HCV co-infection in people living with HIV: a global systematic review and meta-analysis.HIV 感染者中 HCV 合并感染的流行率和负担:一项全球系统评价和荟萃分析。
Lancet Infect Dis. 2016 Jul;16(7):797-808. doi: 10.1016/S1473-3099(15)00485-5. Epub 2016 Feb 25.
9
Cluster of HIV Infections Attributed to Unsafe Injection Practices--Cambodia, December 1, 2014-February 28, 2015.2014 年 12 月 1 日-2015 年 2 月 28 日柬埔寨归因于不安全注射行为的 HIV 感染聚集性病例。
MMWR Morb Mortal Wkly Rep. 2016 Feb 19;65(6):142-5. doi: 10.15585/mmwr.mm6506a2.
10
Diabetes and Hepatitis C: A Two-Way Association.糖尿病与丙型肝炎:双向关联
Front Endocrinol (Lausanne). 2015 Sep 14;6:134. doi: 10.3389/fendo.2015.00134. eCollection 2015.